Panic Disorder

... Green Bay Press-Gazette - Threat of blindness leads ex-Packer to benefit Current Green Bay 3°FSunnyForecast » Find events » Send event » Find a job » Resumes » Find a car » Place an ad » Find homes » Place an ad » Rentals » Place an ad » Coupons » On sale » Find stuff » Place an ad » Meet your Match » Gateway to Wisconsin » Advertisement Advertisement Local Special Sections- Advertisement Prevent Blindness benefit What: 11th Annual Celebrity Luau to benefit Prevent Blindness Wisconsin Northeast Chapter.

The luau features a Hawaiian-style buffet served by local celebrities; South Pacific Sounds, a local Polynesian dance show; raffle for a trip for two to Hawaii; limbo contest; silent auction; dancing.

When: 6 to 11:30 p.m.

Saturday Where: SC Grand, 1250 Mid-Valley Drive, Lawrence Special guest: Former Packers lineman Blaise Winter Goal: To attract 560 guests and raise $40,000 to fund vision screenings, education programs, eye health seminars and workshops in Northeastern Wisconsin.

The Northeast Chapter screens nearly 4,000 children and adults annually.

Tickets: For information, call Nancy Nabak at Prevent Blindness Wisconsin at (920) 432-5466 or e-mail pbwnortheast@sbcglobal.net.

Advertisement Posted February 20, 2006 Thr...

... Study Finds Cymbalta® Was As Safe And Well-Tolerated As Routine Drug Treatments For Diabetic Nerve Pain home xml feeds news alerts weekly newsletter advertise accessibility contact Archive Search Medical Abbreviations www.medilexicon.com Study Finds Cymbalta® Was As Safe And Well-Tolerated As Routine Drug Treatments For Diabetic Nerve Pain Main Category: Public Health News Article Date: 20 Feb 2006 - 9:00am (UK)A long-term study of more than 200 patients found that Cymbalta (duloxetine HCl) is as safe and well- tolerated as current routine care that uses one or more medications for the management of pain caused by diabetic nerve damage.

Study findings also show that Cymbalta did not adversely affect the progression of diabetes or many of the complications associated with the illness, such as damage to the nerves, kidneys and eyes.

The findings, published in the current issue of the Journal of Palliative Medicine, "suggest that with Cymbalta, clinicians can expect a similar level of quality of life without compromising safety or tolerability," explained Dr.

Tim Smith, a study author and clinical instructor of medicine at Washington University School of Medicine.

The 52-week study compared Cymbalta, a non-narcotic prescription medication for the management of diabetic nerve pain, to routine care, defined as therapies that the investigator and the patient believed permitted the optimal benefit to the patient, such as anticonvulsants and antidepressants.

The most commonly us...

... The Enquirer - Taming post-traumatic stress Subscribe Now ENQUIRER CONTRIBUTOR Of all the U.S.

soldiers and all the Iraqi citizens exposed to combat and terror, roughly one in 10 will end up with post-traumatic stress disorder, or PTSD.The amazing good news is that the other nine of 10 war survivors will not develop PTSD.But, for those the fother 10 per cent who are not so lucky or not so resilient, PTSD is like having wild horses locked in the barn.

For long stretches, sometimes years, life might go on without trouble.

The horses are quiet.

The natural coping instincts work well enough.

Then, for mysterious reasons, the demands of life wear down the coping instincts, and anxiety breaks through in the form of nightmares, flashbacks and panic attacks.They can be as overwhelming as the original trauma, and they don't go away.Scott Rauch, a neuroscientist at Massachusetts General Hospital, has identified a set ...